All Stories

  1. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas

    Article • iScience, October 2020, Elsevier

    Claudio Tripodo

  2. SPARC regulation of PMN clearance protects from pristane induced lupus and rheumatoid arthritis

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Claudio Tripodo

  3. Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche

    Article • Blood, July 2020, American Society of Hematology

    Claudio Tripodo

  4. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs

    Article • Cancer Research, April 2020, American Association for Cancer Research (AACR)

    Claudio Tripodo

  5. Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

    Article • Cancer Research, March 2020, American Association for Cancer Research (AACR)

    Claudio Tripodo

  6. ATR expands embryonic stem cell fate potential in response to replication stress

    Article • eLife, March 2020, eLife

    Claudio Tripodo

  7. Transcriptional profiles and stromal changes reveal bone marrow adaptation to early breast cancer in association with deregulated circulating microRNAs

    Article • Cancer Research, November 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  8. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome

    Article • Nature Communications, November 2019, Springer Science + Business Media

    Claudio Tripodo

  9. Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis

    Article • Journal of Autoimmunity, September 2019, Elsevier

    Claudio Tripodo

  10. Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

    Article • PLoS ONE, August 2019, PLOS

    Claudio Tripodo

  11. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities

    Article • Frontiers in Immunology, June 2019, Frontiers

    Claudio Tripodo

  12. Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma

    Article • Virchows Archiv, June 2019, Springer Science + Business Media

    Claudio Tripodo

  13. IL‐10‐producing B cells are characterized by a specific methylation signature

    Article • European Journal of Immunology, May 2019, Wiley

    Claudio Tripodo

  14. The B‐cell receptor in control of tumor B‐cell fitness: Biology and clinical relevance

    Article • Immunological Reviews, March 2019, Wiley

    Claudio Tripodo

  15. Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity

    Article • Journal of Leukocyte Biology, February 2019, Wiley

    Claudio Tripodo

  16. Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells

    Article • Cancer Research, February 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  17. Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

    Article • Clinical Cancer Research, February 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  18. WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

    Article • Oncogene, January 2019, Springer Science + Business Media

    Claudio Tripodo

  19. Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

    Article • International Journal of Cancer, January 2019, Wiley

    Claudio Tripodo

  20. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming

    Article • Cell Reports, December 2018, Elsevier

    Claudio Tripodo

  21. Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

    Article • Cytokine & Growth Factor Reviews, December 2018, Elsevier

    Claudio Tripodo

  22. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

    Article • British Journal of Haematology, November 2018, Wiley

    Claudio Tripodo

  23. Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

    Article • Haematologica, October 2018, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  24. Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer

    Article • Frontiers in Immunology, August 2018, Frontiers

    Claudio Tripodo

  25. Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth

    Article • Cancer Immunology Research, July 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  26. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer

    Article • Cancer Immunology Research, March 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  27. Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence

    Article • Science Translational Medicine, February 2018, American Association for the Advancement of Science

    Claudio Tripodo, Daniela de Totero

  28. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

    Article • Science Translational Medicine, January 2018, American Association for the Advancement of Science

    Claudio Tripodo

  29. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing

    Article • Molecular Biology Reports, December 2017, Springer Science + Business Media

    Claudio Tripodo

  30. Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells

    Article • Cancer Letters, December 2017, Elsevier

    Claudio Tripodo

  31. IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis

    Article • OncoImmunology, November 2017, Taylor & Francis

    Claudio Tripodo

  32. Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth

    Article • Frontiers in Immunology, November 2017, Frontiers

    Claudio Tripodo

  33. Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses

    Article • Trends in Immunology, September 2017, Elsevier

    Claudio Tripodo

  34. Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities

    Article • The FASEB Journal, August 2017, Federation of American Societies For Experimental Biology (FASEB)

    SILVIA MIOTTI, Claudio Tripodo

  35. The good and bad of targeting cancer-associated extracellular matrix

    Article • Current Opinion in Pharmacology, August 2017, Elsevier

    Claudio Tripodo

  36. Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

    Article • Hematological Oncology, July 2017, Wiley

    Claudio Tripodo

  37. Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer

    Article • OncoImmunology, June 2017, Taylor & Francis

    Claudio Tripodo

  38. Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

    Article • Clinical Cancer Research, June 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  39. Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling

    Article • Cancer Research, May 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  40. IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia

    Article • Apmis, May 2017, Wiley

    Dr Ottavio Piccin, Donato Zipeto, Claudio Tripodo

  41. Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

    Article • Cancer Immunology Immunotherapy, May 2017, Springer Science + Business Media

    Claudio Tripodo

  42. Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10 + phenotype

    Article • Clinical Immunology, May 2017, Elsevier

    Claudio Tripodo

  43. Mast cells are associated with the onset and progression of celiac disease

    Article • Journal of Allergy and Clinical Immunology, April 2017, Elsevier

    Claudio Tripodo

  44. Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas

    Article • Molecular Cancer Research, January 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  45. Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β

    Article • Molecular Cancer Therapeutics, December 2016, American Association for Cancer Research (AACR)

    Claudio Tripodo

  46. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

    Article • The Lancet Haematology, October 2016, Elsevier

    Claudio Tripodo

  47. The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma

    Article • Oncotarget, September 2016, Impact Journals, LLC

    Claudio Tripodo

  48. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity

    Article • Cell Reports, September 2016, Elsevier

    Claudio Tripodo

  49. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    Claudio Tripodo

  50. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

    Article • Journal of Hepatology, March 2016, Elsevier

    Claudio Tripodo

  51. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

    Article • Nature Communications, February 2016, Springer Science + Business Media

    Claudio Tripodo

  52. MEF2C and SOCS2 in stemness regulation

    Article • Oncoscience, December 2015, Impact Journals, LLC

    Claudio Tripodo

  53. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers

    Article • Oncotarget, December 2015, Impact Journals, LLC

    Claudio Tripodo

  54. A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles

    Article • Nano Research, December 2015, Tsinghua University Press

    Claudio Tripodo

  55. A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome

    Article • Oncoscience, November 2015, Impact Journals, LLC

    Claudio Tripodo

  56. AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression

    Article • Oncogene, October 2015, Springer Science + Business Media

    Claudio Tripodo

  57. Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment

    Article • OncoImmunology, August 2015, Taylor & Francis

    Claudio Tripodo

  58. Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma

    Article • OncoImmunology, August 2015, Taylor & Francis

    Claudio Tripodo

  59. RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis

    Article • Cancer Cell, August 2015, Elsevier

    Claudio Tripodo

  60. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas

    Article • Oncotarget, July 2015, Impact Journals, LLC

    Claudio Tripodo

  61. Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth

    Article • Cancer Research, July 2015, American Association for Cancer Research (AACR)

    Claudio Tripodo

  62. Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

    Article • Leukemia & Lymphoma, July 2015, Taylor & Francis

    Claudio Tripodo

  63. Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

    Article • International Journal of Nanomedicine, June 2015, Dove Medical Press

    Claudio Tripodo

  64. “Cancer Bio-Immunotherapy in Siena”: Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9–11, 2014

    Article • Cancer Immunology Immunotherapy, May 2015, Springer Science + Business Media

    Claudio Tripodo

  65. SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B

    Article • The Journal of Pathology, April 2015, Wiley

    Claudio Tripodo

  66. SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias

    Article • Cancer Research, April 2015, American Association for Cancer Research (AACR)

    Claudio Tripodo

  67. HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

    Article • Blood, March 2015, American Society of Hematology

    Claudio Tripodo

  68. The ins and outs of osteopontin

    Article • OncoImmunology, March 2015, Taylor & Francis

    Claudio Tripodo

  69. IFI16Expression Is Related to Selected Transcription Factors during B-Cell Differentiation

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Professor Marco De Andrea, Claudio Tripodo

  70. The Hepatic Expression of Vitamin D Receptor Is Inversely Associated With the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2015, Endocrine Society

    Claudio Tripodo

  71. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus

    Article • Frontiers in Microbiology, December 2014, Frontiers

    Claudio Tripodo

  72. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified

    Article • Blood Cancer Journal, November 2014, Springer Science + Business Media

    Claudio Tripodo

  73. Mast Cells Boost Myeloid-Derived Suppressor Cell Activity and Contribute to the Development of Tumor-Favoring Microenvironment

    Article • Cancer Immunology Research, October 2014, American Association for Cancer Research (AACR)

    Claudio Tripodo

  74. The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma

    Article • Leukemia, October 2014, Springer Science + Business Media

    Claudio Tripodo

  75. Mast Cells Control the Expansion and Differentiation of IL-10–Competent B Cells

    Article • The Journal of Immunology, September 2014, The American Association of Immunologists

    Claudio Tripodo

  76. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

    Article • Blood, September 2014, American Society of Hematology

    Claudio Tripodo

  77. Osteopontin Shapes Immunosuppression in the Metastatic Niche

    Article • Cancer Research, July 2014, American Association for Cancer Research (AACR)

    Claudio Tripodo

  78. Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression

    Article • Annals of Oncology, July 2014, Oxford University Press (OUP)

    Claudio Tripodo

  79. Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue

    Article • Hepatology, June 2014, Wolters Kluwer Health

    Professor Stefania Brozzetti, Claudio Tripodo

  80. Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

    Article • Leukemia, June 2014, Springer Science + Business Media

    Claudio Tripodo

  81. Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies

    Article • OncoImmunology, June 2014, Taylor & Francis

    Claudio Tripodo

  82. PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

    Article • Molecular Oncology, March 2014, Wiley

    Claudio Tripodo

  83. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

    Article • Blood, March 2014, American Society of Hematology

    Claudio Tripodo

  84. C1q as a unique player in angiogenesis with therapeutic implication in wound healing

    Article • Proceedings of the National Academy of Sciences, March 2014, Proceedings of the National Academy of Sciences

    Claudio Tripodo

  85. Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages

    Article • Haematologica, February 2014, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo, Daniela de Totero

  86. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

    Article • Leukemia, February 2014, Springer Science + Business Media

    Claudio Tripodo

  87. Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway

    Article • Leukemia, January 2014, Springer Science + Business Media

    Claudio Tripodo

  88. The Role of Inflammation in Lymphoma

    Article • January 2014, Springer Science + Business Media

    Claudio Tripodo

  89. RNA recognition by human TLR8 can lead to autoimmune inflammation

    Article • The Journal of Experimental Medicine, November 2013, Rockefeller University Press

    Claudio Tripodo

  90. Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms

    Article • Modern Pathology, November 2013, Springer Science + Business Media

    Claudio Tripodo

  91. Defective Stromal Remodeling and Neutrophil Extracellular Traps in Lymphoid Tissues Favor the Transition from Autoimmunity to Lymphoma

    Article • Cancer Discovery, November 2013, American Association for Cancer Research (AACR)

    Claudio Tripodo

  92. Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer

    Article • Cancer Immunology Immunotherapy, October 2013, Springer Science + Business Media

    Claudio Tripodo

  93. New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

    Article • PLoS ONE, September 2013, PLOS

    Claudio Tripodo

  94. Two Patients With History of STEC-HUS, Posttransplant Recurrence and Complement Gene Mutations

    Article • American Journal of Transplantation, June 2013, Wiley

    Claudio Tripodo

  95. Response to Villanacci et al.

    Article • The American Journal of Gastroenterology, April 2013, Wolters Kluwer Health

    Claudio Tripodo

  96. The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR‐221&222‐c‐FOS pathway

    Article • International Journal of Cancer, March 2013, Wiley

    Claudio Tripodo

  97. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation

    Article • Haematologica, January 2013, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  98. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors

    Article • The FASEB Journal, November 2012, Federation of American Societies For Experimental Biology (FASEB)

    Claudio Tripodo

  99. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion

    Article • Blood, October 2012, American Society of Hematology

    Claudio Tripodo

  100. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity

    Article • Blood, October 2012, American Society of Hematology

    Claudio Tripodo

  101. A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of haemolytic uremic syndrome

    Article • Biomedical Papers, September 2012, Palacky University Olomouc

    Dr. Vincenzo D Palumbo, Claudio Tripodo

  102. Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: Two mixing fatal syndromes?

    Article • Medical Hypotheses, July 2012, Elsevier

    Claudio Tripodo

  103. The Aryl Hydrocarbon Receptor Modulates Acute and Late Mast Cell Responses

    Article • The Journal of Immunology, May 2012, The American Association of Immunologists

    Claudio Tripodo

  104. Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas

    Article • Advances in Hematology, January 2012, Hindawi Publishing Corporation

    Claudio Tripodo

  105. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia

    Article • Blood, December 2011, American Society of Hematology

    Claudio Tripodo

  106. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

    Article • Blood, December 2011, American Society of Hematology

    Claudio Tripodo

  107. SPARC Oppositely Regulates Inflammation and Fibrosis in Bleomycin-Induced Lung Damage

    Article • American Journal Of Pathology, December 2011, Elsevier

    Claudio Tripodo

  108. The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses

    Article • Journal of Autoimmunity, December 2011, Elsevier

    Claudio Tripodo

  109. SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis

    Article • PLoS ONE, November 2011, PLOS

    Claudio Tripodo

  110. Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target

    Article • Blood, October 2011, American Society of Hematology

    Claudio Tripodo

  111. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases

    Article • October 2011, Springer Science + Business Media

    PhD Paola Spessotto, Claudio Tripodo

  112. Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers

    Article • Cancer Research, September 2011, American Association for Cancer Research (AACR)

    Claudio Tripodo

  113. Peripheral T-cell lymphoma classification: the matter of cellular derivation

    Article • Expert Review of Hematology, August 2011, Taylor & Francis

    Claudio Tripodo

  114. C1q induces in vivo angiogenesis and promotes wound healing

    Article • Molecular Immunology, August 2011, Elsevier

    Claudio Tripodo

  115. Preeclampsia is associated with defective production of C1q by invasive trophoblast

    Article • Molecular Immunology, August 2011, Elsevier

    Claudio Tripodo

  116. Technical Advance: Soluble OX40 molecule mimics regulatory T cell modulatory activity on FcɛRI-dependent mast cell degranulation

    Article • Journal of Leukocyte Biology, June 2011, Wiley

    Claudio Tripodo

  117. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment

    Article • Leukemia, May 2011, Springer Science + Business Media

    Claudio Tripodo

  118. High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis

    Article • Digestive and Liver Disease, May 2011, Elsevier

    Claudio Tripodo

  119. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

    Article • Blood, March 2011, American Society of Hematology

    Claudio Tripodo

  120. The bone marrow stroma in hematological neoplasms—a guilty bystander

    Article • Nature Reviews Clinical Oncology, March 2011, Springer Science + Business Media

    Claudio Tripodo

  121. How I diagnose and treat splenic lymphomas

    Article • Blood, March 2011, American Society of Hematology

    Claudio Tripodo

  122. Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice

    Article • Laboratory Investigation, February 2011, Springer Science + Business Media

    Claudio Tripodo

  123. Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients

    Article • Antiviral Therapy, January 2011, International Medical Press

    Claudio Tripodo

  124. Pathobiology of Hodgkin Lymphoma

    Article • Advances in Hematology, January 2011, Hindawi Publishing Corporation

    Claudio Tripodo

  125. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

    Article • British Journal of Haematology, December 2010, Wiley

    Claudio Tripodo

  126. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

    Article • Blood, November 2010, American Society of Hematology

    Dr Francesco Bertoni, Claudio Tripodo, Prof. Emanuele Zucca

  127. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9

    Article • The Journal of Experimental Medicine, November 2010, Rockefeller University Press

    Claudio Tripodo

  128. Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors

    Article • Oncogene, November 2010, Springer Science + Business Media

    Claudio Tripodo

  129. Exploratory Study on the Effects of Biodegradable Nanoparticles with Drugs on Malignant B Cells and on a Human/Mouse Model of Burkitt Lymphoma

    Article • Current Clinical Pharmacology, November 2010, Bentham Science Publishers

    Claudio Tripodo

  130. Oncogene-Driven Intrinsic Inflammation Induces Leukocyte Production of Tumor Necrosis Factor That Critically Contributes to Mammary Carcinogenesis

    Article • Cancer Research, October 2010, American Association for Cancer Research (AACR)

    Claudio Tripodo

  131. Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts

    Article • Investigational New Drugs, September 2010, Springer Science + Business Media

    Claudio Tripodo

  132. An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development

    Article • The Journal of Immunology, September 2010, The American Association of Immunologists

    PhD Paola Spessotto, Claudio Tripodo

  133. Mast Cells and Th17 Cells Contribute to the Lymphoma-Associated Pro-Inflammatory Microenvironment of Angioimmunoblastic T-Cell Lymphoma

    Article • American Journal Of Pathology, August 2010, Elsevier

    Claudio Tripodo

  134. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

    Article • Blood, July 2010, American Society of Hematology

    Claudio Tripodo

  135. A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2

    Article • European Journal of Immunology, July 2010, Wiley

    Claudio Tripodo

  136. Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts

    Article • PLoS ONE, June 2010, PLOS

    Claudio Tripodo

  137. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells

    Article • Blood, April 2010, American Society of Hematology

    Claudio Tripodo

  138. Humoral immunotherapy of multiple myeloma: perspectives and perplexities

    Article • Expert Opinion on Biological Therapy, April 2010, Informa Healthcare

    Claudio Tripodo

  139. Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38+CD49d+chronic lymphocytic leukaemia cells

    Article • British Journal of Haematology, March 2010, Wiley

    Claudio Tripodo

  140. Exploring a regulatory role for mast cells: ‘MCregs’?

    Article • Trends in Immunology, March 2010, Elsevier

    Claudio Tripodo

  141. T Cell Large Granular Lymphocytic Leukemia in Association with Sjögren’s Syndrome

    Article • Acta Haematologica, January 2010, Karger Publishers

    Claudio Tripodo

  142. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C

    Article • Hepatology, December 2009, Wiley

    Claudio Tripodo

  143. Gamma-delta T-cell lymphomas

    Article • Nature Reviews Clinical Oncology, November 2009, Springer Science + Business Media

    Claudio Tripodo

  144. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation

    Article • Blood, September 2009, American Society of Hematology

    Claudio Tripodo

  145. P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

    Article • Current Cancer Drug Targets, August 2009, Bentham Science Publishers

    Claudio Tripodo

  146. Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection

    Article • Journal of Viral Hepatitis, June 2009, Wiley

    Claudio Tripodo

  147. CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival

    Article • Cancer Research, April 2009, American Association for Cancer Research (AACR)

    Claudio Tripodo

  148. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

    Article • Blood, April 2009, American Society of Hematology

    Claudio Tripodo

  149. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

    Article • Arthritis & Rheumatism, April 2009, Wiley

    Claudio Tripodo

  150. Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial

    Article • Clinical Lymphoma & Myeloma, April 2009, Elsevier

    Claudio Tripodo

  151. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis

    Article • Journal of Clinical Pathology, March 2009, BMJ

    Claudio Tripodo

  152. CD146+ bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis

    Article • Haematologica, January 2009, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  153. Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report

    Article • Journal of Medical Case Reports, January 2009, Springer Science + Business Media

    Claudio Tripodo

  154. Selection and Characterization of a Novel Agonistic Human Recombinant Anti-Trail-R2 Minibody with Antileukemic Activity

    Article • International Journal of Immunopathology and Pharmacology, January 2009, SAGE Publications

    Claudio Tripodo

  155. An automated image analysis methodology for classifying megakaryocytes in chronic myeloproliferative disorders

    Article • Medical Image Analysis, December 2008, Elsevier

    Claudio Tripodo

  156. Angioimmunoblastic T-cell lymphoma

    Article • Critical Reviews in Oncology/Hematology, December 2008, Elsevier

    Claudio Tripodo

  157. CD4+CD25+ Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction

    Article • Immunity, November 2008, Elsevier

    Claudio Tripodo

  158. In Vivo Biodistribution and Lifetime Analysis of Cy5.5-Conjugated Rituximab in Mice Bearing Lymphoid Tumor Xenograft Using Time-Domain Near-Infrared Optical Imaging

    Article • Molecular Imaging, November 2008, SAGE Publications

    Claudio Tripodo

  159. The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis

    Article • Rheumatology, October 2008, Oxford University Press (OUP)

    Claudio Tripodo

  160. Carbamazepine Transbuccal Delivery: The Histo-Morphological Features of Reconstituted Human Oral Epithelium and Buccal Porcine Mucosae in the Transmucosal Permeation

    Article • International Journal of Immunopathology and Pharmacology, October 2008, SAGE Publications

    Prof Lorenzo Lo Muzio, Claudio Tripodo

  161. An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

    Article • Current Pharmaceutical Design, July 2008, Bentham Science Publishers

    Claudio Tripodo

  162. Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium

    Article • Molecular Immunology, May 2008, Elsevier

    Claudio Tripodo

  163. In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab

    Article • Cancer Research, November 2007, American Association for Cancer Research (AACR)

    Claudio Tripodo

  164. Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions

    Article • Histopathology, November 2007, Wiley

    Claudio Tripodo

  165. Use of intrapleural bortezomib in myelomatous pleural effusion

    Article • British Journal of Haematology, November 2007, Wiley

    Claudio Tripodo

  166. Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4

    Article • Cell Stem Cell, October 2007, Elsevier

    Dr ANNA BARBARA DI STEFANO, Claudio Tripodo

  167. Release of naltrexone on buccal mucosa: Permeation studies, histological aspects and matrix system design

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2007, Elsevier

    Claudio Tripodo

  168. C1q Production by Bone Marrow Stromal Cells

    Article • Scandinavian Journal of Immunology, March 2007, Wiley

    Claudio Tripodo

  169. Associations between Notch-2, Akt-1 and HER2/neu Expression in Invasive Human Breast Cancer: A Tissue Microarray Immunophenotypic Analysis on 98 Patients

    Article • Pathobiology, January 2007, Karger Publishers

    Claudio Tripodo

  170. Constant Detection of Cyclooxygenase 2 in Terminal Stages of Myeloid Maturation

    Article • Acta Haematologica, November 2006, Karger Publishers

    Claudio Tripodo

  171. Thyroid Sarcoidosis as a Unique Localization

    Article • Thyroid, November 2006, Mary Ann Liebert Inc

    Claudio Tripodo

  172. Reply to Pich et al.: intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study

    Article • European Journal Of Haematology, October 2006, Wiley

    Claudio Tripodo

  173. Small Bowel Angiodysplasia Associated with von Willebrand's Disease: Report of a Case

    Article • Surgery Today, June 2006, Springer Science + Business Media

    Claudio Tripodo

  174. Splenic marginal zone lymphoma: a prognostic model for clinical use

    Article • Blood, June 2006, American Society of Hematology

    Claudio Tripodo

  175. Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

    Article • European Journal Of Haematology, February 2006, Wiley

    Claudio Tripodo

  176. Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement

    Article • Leukemia & Lymphoma, January 2006, Taylor & Francis

    Claudio Tripodo

  177. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

    Article • European Journal Of Haematology, August 2005, Wiley

    Claudio Tripodo

  178. Identification of CD162 in plasma-cell dyscrasia

    Article • The Lancet Oncology, August 2005, Elsevier

    Claudio Tripodo

  179. 16. Clinical-Pathological Correlations

    Article • Annals of Oncology, June 2005, Elsevier

    Claudio Tripodo

  180. Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis

    Article • World Journal of Gastroenterology, January 2005, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Claudio Tripodo

  181. Splenic marginal zone lymphoma with or without villous lymphocytes

    Article • Cancer, October 2004, Wiley

    Claudio Tripodo

  182. Re: ?Splenic marginal zone B-cell lymphoma associated with primary Sj�gren?s syndrome?

    Article • Clinical Rheumatology, September 2004, Springer Science + Business Media

    Claudio Tripodo

  183. Bone marrow biopsy in Hodgkin's lymphoma

    Article • European Journal Of Haematology, July 2004, Wiley

    Claudio Tripodo

  184. Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment

    Article • The Hematology Journal, January 2004, Springer Science + Business Media

    Claudio Tripodo

  185. Primary T-cell rich B-cell lymphoma of the penis: a first case

    Article • BJU International, May 2003, Wiley

    Claudio Tripodo